摘要
Objective To investigate and verify a novel acute graft versus host disease (aGVHD) prevention protocol in the context of haploidentical hematopoietic stem cell transplantation (haplo-HSCT).Methods Patients who underwent haplo-HSCT in our center between January 2022 and December 2022 were included.
作者
LI Xiaoping
李小平(Dept Hematol,920th Hosp,Joint Logistics Support Force,Kunming 650000,China)